Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-08

Clinical Trial Update: GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a guselkumab intervention with diet evaluation for pouchitis is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guselkumab (guselkumab)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Pouchitis | Phase 4 | Status: NOT_YET_RECRUITING